title: Respiratory mechanics and bronchodilator responsiveness in patients with the adult respiratory distress syndrome.
abstract: OBJECTIVE
  To study the effects of salbutamol (a selective beta 2-adrenergic receptor agonist) on respiratory mechanics in patients with the adult respiratory distress syndrome (ARDS).
  
  
  METHODS
  Prospective study.
  
  
  METHODS
  ICU in a university hospital.
  
  
  METHODS
  Seven mechanically ventilated, paralyzed ARDS patients.
  
  
  METHODS
  Measurements of respiratory system compliance, maximum, and minimum inspiratory resistance (by the end-inspiratory occlusion method during constant flow inflation) were performed at 0, 5, 10 cm H2O positive end-expiratory pressure, both before and at least 30 mins after the start of a continuous iv infusion of salbutamol (15 micrograms/min). Minimum inspiratory resistance represents the ohmic air flow resistance, while maximum inspiratory resistance includes minimum inspiratory resistance plus the effective additional resistance due to stress adaptation and to time constant inhomogeneities. Air flow was measured at the airway connector and tracheal pressure near the central end of the artificial airway.
  
  
  RESULTS
  Maximum inspiratory resistance, minimum inspiratory resistance, and additional resistance were higher than the values reported for normal anesthetized subjects. On average, salbutamol caused a decrease in maximum and minimum inspiratory resistances (from 6.48 +/- 2.56 to 4.67 +/- 1.74 and from 4.06 +/- 2.12 to 2.07 +/- 0.95 cm H2O/L/sec, respectively). Positive end-expiratory pressure increased additional resistance, whereas it decreased minimum inspiratory resistance. No interaction was found between positive end-expiratory pressure and salbutamol. Respiratory system compliance was not significantly affected by salbutamol nor by positive end-expiratory pressure.
  
  
  CONCLUSIONS
  In ARDS patients, salbutamol decreases the abnormally high airway resistance, by reducing minimum resistance, but has no effect on the effective additional resistance.
authors.affiliation: Department of Anesthesia and Intensive Care, University of Milan, San Gerardo Hospital, Monza (MI), Italy.
authors.forename: A
authors.initials: A
authors.lastname: Pesenti
authors.forename: P
authors.initials: P
authors.lastname: Pelosi
authors.forename: N
authors.initials: N
authors.lastname: Rossi
authors.forename: M
authors.initials: M
authors.lastname: Aprigliano
authors.forename: L
authors.initials: L
authors.lastname: Brazzi
authors.forename: R
authors.initials: R
authors.lastname: Fumagalli
mesh_terms: D000293:Adolescent; D000328:Adult; D000403:Airway Resistance / Q000187:drug effects; D000420:Albuterol / Q000494:pharmacology* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011175:Positive-Pressure Respiration; D011446:Prospective Studies; D012123:Pulmonary Ventilation / Q000187:drug effects; D012119:Respiration / Q000187:drug effects; D012121:Respiration, Artificial; D012128:Respiratory Distress Syndrome / Q000503:physiopathology* / Q000628:therapy; D015656:Respiratory Mechanics / Q000187:drug effects*
chemical_list: D000420:Albuterol